Teva Pharmaceutical Industries Ltd news
Results Teva Pharmaceutical Industries Ltd has filed with the SEC, each with its AAOIFI halal screening.
- Teva Pharmaceutical Industries Ltd reports $4.39 billion revenue for quarter ended September 30, 2026, down 1.9%
- Teva Pharmaceutical Industries Ltd reports $4.14 billion revenue for quarter ended June 30, 2026, down 0.8%
- Teva Pharmaceutical Industries Ltd reports $3.98 billion revenue for quarter ended March 31, 2026
- Teva Pharmaceutical Industries Ltd reports $17.26 billion revenue for fiscal year ended December 31, 2025, up 4.3%
Recent event reports (Form 8-K)
- Director or senior officer change
- Announced results of operations
- Director or senior officer change
- Entered a material agreement; Took on a new financial obligation (debt)
- Announced results of operations
- Announced results of operations
- Announced results of operations
- Announced results of operations
- Entered a material agreement; Took on a new financial obligation (debt)
- Announced results of operations
Listed from the company's filing index on the SEC website; open the filing for the details.